Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AARD
GNLX
Add up to 3 more stocks
AARD
Aardvark Therapeutics, Inc. Common Stock
-5.65%
$4.92-0.29Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$107.78M
52W Range
$3.35 - $17.94
GNLX
Genelux Corporation
-2.25%
$2.54-0.06Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$113.97M
52W Range
$2.29 - $8.54
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.44 | 7.07 |
| P/S Ratio | N/A | 14245.80 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | -7075.0% |
| Operating Margin | 0.0% | -415175.0% |
| Net Margin | 0.0% | -422412.5% |
| ROE | -93.4% | -209.7% |
| ROA | -85.8% | -129.0% |
| ROIC | -98.0% | -192.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.63 | 2.39 |
| Quick Ratio | 12.63 | 2.39 |
| Debt/Equity | 0.01 | 0.15 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.